FIELD: medicine.
SUBSTANCE: what is described is application of a betulonic acid derivative as a cytostatic polychemotherapy corrector improving its antitumour action, reducing its toxic liver effect and exhibiting anti-inflammatory activity.
EFFECT: compound intensifies the antitumour effect of cytostatic polychemotherapy, effectively reduces its toxic action on healthy liver cells, exhibits anti-inflammatory properties and low toxicity.
6 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CORRECTOR OF CYTOSTATIC POLYCHEMOTHERAPY | 2007 |
|
RU2353623C1 |
| CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
| N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
| N-[3-OXO-LUPANO-28-YL]-MORPHOLINE - AGENT FOR CORRECTION OF CYTOTOXIC LIVER DAMAGES WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY | 2011 |
|
RU2461563C1 |
| AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
| METHOD FOR ENHANCING OF CYCLOPHOSPHAN ANTITUMOR AND ANTIMETASTATIC ACTIVITY IN EXPERIMENT | 2004 |
|
RU2270682C2 |
| AGENT FOR TREATING OSTEOMYELITIS | 2015 |
|
RU2604124C1 |
| ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
| MEANS FOR CHRONIC ATROPHIC GASTRITIS TREATMENT | 2016 |
|
RU2623866C1 |
| ANTITUMOUR AGENT, RELATED TO GROUP OF METAL-ORGANIC DERIVATIVES OF POLYACRYLIC ACID | 2008 |
|
RU2372091C1 |
